# Precise Therapy for mCRPC Patients Through Whole Exome Sequencing(PTtWES)

> **NCT04126915** · — · UNKNOWN · sponsor: **Yinghao Sun** · enrollment: 200 (estimated)

## Conditions studied

- Castration-Resistant Prostatic Cancer

## Interventions

- **GENETIC:** Whole Exome Sequencing

## Key facts

- **NCT ID:** NCT04126915
- **Lead sponsor:** Yinghao Sun
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-11-08
- **Primary completion:** 2022-10-08
- **Final completion:** 2024-10-08
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2019-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04126915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04126915, "Precise Therapy for mCRPC Patients Through Whole Exome Sequencing(PTtWES)". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT04126915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*